BioLife Solutions (BLFS)

• Market cap: $1.2B
• 1 day: -2.63%
• 5 days: -5.16%
• 1 month: -5.06%
• 3 months: 3.39%
• 6 months: 24.53%
• Year to date: 62.02%
• 1 year: 62.02%
• 5 years: 61.21%
• 10 years: 1,422.94%
• Sector: Healthcare
• Industry: Electromedical & Electrotherapeutic Apparatus

About: BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

Employees: 414

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

483% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 6

72% more call options, than puts

Call options by funds: $210K | Put options by funds: $122K

18% more funds holding

Funds holding: 164 [Q2] → 193 (+29) [Q3]

13% more capital invested

Capital invested by funds: $1.01B [Q2] → $1.14B (+$128M) [Q3]

3.87% less ownership

Funds ownership: 102.34% [Q2] → 98.47% (-3.87%) [Q3]

14% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 65

25% less funds holding in top 10

Funds holding in top 10: 4 [Q2] → 3 (-1) [Q3]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $27 4% upside
• Avg. target: $31 18% upside
• High target: $33 27% upside

5 analyst ratings

• positive: 5 100%
• neutral: 0 0%
• negative: 0 0%

Benchmark Robert Wasserman 54% 1-year accuracy 27 / 50 met price target	16% upside $30	Buy Reiterated	19 Dec 2024
Keybanc Paul Knight 25% 1-year accuracy 2 / 8 met price target	27% upside $33	Overweight Maintained	13 Dec 2024
HC Wainwright & Co. Raghuram Selvaraju 41% 1-year accuracy 128 / 311 met price target	4% upside $27	Buy Maintained	18 Nov 2024
TD Cowen Steven Mah 50% 1-year accuracy 3 / 6 met price target	20% upside $31	Buy Maintained	13 Nov 2024
Craig-Hallum Matt Hewitt 52% 1-year accuracy 13 / 25 met price target	24% upside $32	Buy Maintained	13 Nov 2024